•
Sep 30, 2021

REGENXBIO Q3 2021 Earnings Report

Total Revenue
$30.8M
Previous year: $98.9M
-68.9%
EPS
-$1.37
Previous year: $0.23
-695.7%
Gross Profit
$16.7M
Previous year: $81.5M
-79.6%
Cash and Equivalents
$228M
Previous year: $93.2M
+145.0%
Free Cash Flow
-$55.1M
Previous year: -$42.5M
+29.4%
Total Assets
$800M
Previous year: $541M
+47.9%

REGENXBIO

REGENXBIO